Table 2.

Characteristics of E2A-HLF Leukemic Mice

Mouse No. (sex) Age at Diagnosis (mo) Macroscopic Tumor SitesHematological Examination Surface Marker Analysis DNA Status (TCR)
WBC (×103/μL)Hb (g/dL) Plt (×103/μL)
      Thy1.2 (+)  
1-17-9  5.5  Thy, Spl, LN  43.8  4.5  6.2  CD4 (−) CD8 (+)  G/R 
(M)    (>90% lymphoblasts)  B220 (−)  
      Thy1.2 (+)  
2-17-2  6.0 Thy, Spl, LN  20.5  8.0  10.5  CD4 (+) CD8 (+)  G/R 
(F)    (>90% lymphoblasts)  B220 (−)  
      Thy1.2 (+)  
2-17-8-2  4.2 Thy, Spl, LN  19.8  7.7  22.2  CD4 (+) CD8 (−) G/R  
(F)    (>90% lymphoblasts)  B220 (−)  
      Thy1.2 (+)  
2-17-8-4 5.2  Thy, Spl, LN  15.6  8.5  23.3  CD4 (+) CD8 (−)  G/R  
(F)    (>90% lymphoblasts)  B220 (−)  
      Thy1.2 (+)  
2-17-10-8  3.1  Thy, Spl, LN  52.3  8.1  30.1 CD4 (+) CD8 (−)  G/R  
(M)    (>90% lymphoblasts)  B220 (−) 
Mouse No. (sex) Age at Diagnosis (mo) Macroscopic Tumor SitesHematological Examination Surface Marker Analysis DNA Status (TCR)
WBC (×103/μL)Hb (g/dL) Plt (×103/μL)
      Thy1.2 (+)  
1-17-9  5.5  Thy, Spl, LN  43.8  4.5  6.2  CD4 (−) CD8 (+)  G/R 
(M)    (>90% lymphoblasts)  B220 (−)  
      Thy1.2 (+)  
2-17-2  6.0 Thy, Spl, LN  20.5  8.0  10.5  CD4 (+) CD8 (+)  G/R 
(F)    (>90% lymphoblasts)  B220 (−)  
      Thy1.2 (+)  
2-17-8-2  4.2 Thy, Spl, LN  19.8  7.7  22.2  CD4 (+) CD8 (−) G/R  
(F)    (>90% lymphoblasts)  B220 (−)  
      Thy1.2 (+)  
2-17-8-4 5.2  Thy, Spl, LN  15.6  8.5  23.3  CD4 (+) CD8 (−)  G/R  
(F)    (>90% lymphoblasts)  B220 (−)  
      Thy1.2 (+)  
2-17-10-8  3.1  Thy, Spl, LN  52.3  8.1  30.1 CD4 (+) CD8 (−)  G/R  
(M)    (>90% lymphoblasts)  B220 (−) 

Abbreviations: M, male; F, female; Thy, thymus; Spl, spleen; LN, lymph node; WBC, white blood cell count; G, germline; R, rearranged.

Close Modal

or Create an Account

Close Modal
Close Modal